KW-3357

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for KW-3357, covering 2017-03-24 to 2024-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KW-3357 in Congenital Antithrombin Deficiency [Phase 1]